Skip to main content
Michael Durkin, MD, Infectious Disease, Saint Louis, MO, Barnes-Jewish Hospital

MichaelDurkinMDMPH

Infectious Disease Saint Louis, MO

Healthcare Associated Infections

Physician

Dr. Durkin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Durkin's full profile

Already have an account?

  • Office

    Washington University School of Medicine
    660 South Euclid Ave
    Saint Louis, MO 63110
    Phone+1 314-362-5000
  • Is this information wrong?

Summary

  • Dr. Michael Durkin is an infectious disease specialist in Saint Louis, MO and is affiliated with Barnes-Jewish Hospital and Washington University School of Medicine. He received his medical degree from Medical College of Wisconsin and has been in practice 9 years. He specializes in healthcare associated infections and is experienced in general infectious disease, public health, epidemiology, infection control, and antibiotic stewardship.

Education & Training

  • University of North Carolina
    University of North CarolinaMPH, Epidemiology, 2013 - 2015
  • Duke University Hospital
    Duke University HospitalFellowship, Infectious Disease, 2012 - 2015
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2008 - 2011
  • Medical College of Wisconsin
    Medical College of WisconsinClass of 2008

Certifications & Licensure

  • MO State Medical License
    MO State Medical License 2011 - 2025
  • NC State Medical License
    NC State Medical License 2012 - 2016
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Fellow Society for Healthcare Epidemiology of America, 2022
  • Fellow Infectious Diseases Society of America, 2021

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Addiction Medicine Consultations Reduce Readmission Rates for Patients with Serious Infections from Opioid Use Disorder  
    David K Warren, Michael J Durkin, Evan S Schwarz, Clinical Infectious Diseases

Books/Book Chapters

  • Join now to see all

Press Mentions

  • IDSA Honors 199 Distinguished Clinicians, Scientists with FIDSA Designation
    IDSA Honors 199 Distinguished Clinicians, Scientists with FIDSA DesignationNovember 16th, 2021
  • Halting Opioid Abuse Aim of Several Grants from NIH, CDC
    Halting Opioid Abuse Aim of Several Grants from NIH, CDCDecember 3rd, 2019

Grant Support

  • Informatics Approaches to Understand and Reduce Inappropriate Antibiotic Prescribing by DentistsNIH(NIDCR)2023–2028
  • Comparative Risk of Oral Complications Associated with Medications for Opioid Use Disorder: A Mixed-Methods ApproachNIH (NIDCR)2023–2028
  • Identifying Optimal Antibiotic Regimens to Treat Urinary Tract Infections During PregnancyNIH(NICHD)2022–2027
  • Washington University & BJC Epicenter to Prevent Healthcare Associated Infections & Antibiotic ResistanceCDC2021–2026
  • Using Implementation Science and Informatics to Develop and Pilot Test Antibiotic Stewardship Clinical Decision SupportNIH(NIDCR)2021–2026
  • Impact of removing low yield penicillin allergy alerts on surgical site infection ratesAHRQ2024–2025
  • Dental Safety of Transmucosal Buprenorphine Among Individuals Receiving OpioidsNIH(NIDA)2023–2025
  • Southeastern Pennsylvania Adult and Pediatric Prevention Epicenter NetworkCDC(NCEZID)2020–2025
  • Stakeholders' Perceptions of Consensus Guidelines about Antibiotics for Asymptomatic BacteriuriaWashington University Institute for Clinical and Translational Sciences2023–2024
  • Moving Upstream – Expanding Harm Reduction Training and Low‐Barrier Care for Unstably Housed People Who Inject DrugsWashington University Institute for Public Health2023–2024
  • Piloting a Shared Decision-Making Aid for Reducing Stigma in Drug Use and HIV Harm Reduction in a Rural SettingNIDA2021–2023
  • Evaluation of Aerosol Composition in Dental SettingsNIH(NIDCR)2021–2022
  • Dissemination and Implementation of a HCV telehealth program for persons who inject drugsWashington University ICTS2021–2022
  • Determining the acceptability and feasibility of mobile-health approaches to gather clinical information from patients at home following hospital dischargeNCATS2020–2022
  • Loan Repayment ProgramNIH (NIAID and NIDCR)2017–2022
  • Research on the cost of inappropriate antibiotic prescribing in outpatient healthcare settingsPew Charitable Trusts2020–2021
  • Assessment of Personal Protective Equipment for Dental Healthcare ProfessionalsNIH (NIDCR)2020–2021
  • Evaluation of Aerosol Generating Procedures in Dental SettingsNIH (NIDCR)2020–2021
  • Increasing use of MAT to address opioid use among patients with bacterial and fungal infections related to injection drug use - RuralCDC SHEPheRD2019–2021
  • Increasing use of MAT to address opioid use among patients with bacterial and fungal infections related to injection drug use - UrbanCDC SHEPheRD Contract2019–2021
  • Washington University & BJC Epicenter for Prevention of Healthcare Associated InfectionsCDC2016–2021
  • Antimicrobial Stewardship ActivitiesCDC2018–2020
  • KL2Washington University ICTS/NIH (NCATS)2016–2019

Professional Memberships

Hospital Affiliations